GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (HKSE:00241) » Definitions » EV-to-EBITDA

Alibaba Health Information Technology (HKSE:00241) EV-to-EBITDA : 39.41 (As of May. 02, 2024)


View and export this data going back to 1972. Start your Free Trial

What is Alibaba Health Information Technology EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Alibaba Health Information Technology's enterprise value is HK$39,799 Mil. Alibaba Health Information Technology's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was HK$1,010 Mil. Therefore, Alibaba Health Information Technology's EV-to-EBITDA for today is 39.41.

The historical rank and industry rank for Alibaba Health Information Technology's EV-to-EBITDA or its related term are showing as below:

HKSE:00241' s EV-to-EBITDA Range Over the Past 10 Years
Min: -5218.55   Med: -159.42   Max: 4318.32
Current: 34.31

During the past 13 years, the highest EV-to-EBITDA of Alibaba Health Information Technology was 4318.32. The lowest was -5218.55. And the median was -159.42.

HKSE:00241's EV-to-EBITDA is ranked worse than
88.02% of 459 companies
in the Healthcare Providers & Services industry
Industry Median: 13.22 vs HKSE:00241: 34.31

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-02), Alibaba Health Information Technology's stock price is HK$3.28. Alibaba Health Information Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.066. Therefore, Alibaba Health Information Technology's PE Ratio for today is 49.70.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Alibaba Health Information Technology EV-to-EBITDA Historical Data

The historical data trend for Alibaba Health Information Technology's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alibaba Health Information Technology EV-to-EBITDA Chart

Alibaba Health Information Technology Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,132.54 1,903.56 535.06 -240.56 91.15

Alibaba Health Information Technology Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -240.56 - 91.15 -

Competitive Comparison of Alibaba Health Information Technology's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's EV-to-EBITDA falls into.



Alibaba Health Information Technology EV-to-EBITDA Calculation

Alibaba Health Information Technology's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=39799.260/1009.879
=39.41

Alibaba Health Information Technology's current Enterprise Value is HK$39,799 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alibaba Health Information Technology's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was HK$1,010 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alibaba Health Information Technology  (HKSE:00241) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Alibaba Health Information Technology's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.28/0.066
=49.70

Alibaba Health Information Technology's share price for today is HK$3.28.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alibaba Health Information Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.066.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Alibaba Health Information Technology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Alibaba Health Information Technology (HKSE:00241) Business Description

Traded in Other Exchanges
Address
Guanghua Road, 65/F, CITIC Tower, Building 1, No.10, Jianwai Subdistrict, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Alibaba Health Information Technology (HKSE:00241) Headlines

No Headlines